SLC5A1 and triple-negative breast carcinoma: For instance, in triple-negative breast cancer (TNBC) models, SGLT1 expression significantly correlated with tumor size and clinical-pathological characteristics, presenting SGLT1 as a prognostic marker (Liu et al., 2019) and its SGLT1 overexpression correlates with worse outcomes in colorectal cancer patients (Guo et al., 2011).